Fora Capital, LLC Ligand Pharmaceuticals Inc Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $26,675 - $36,731	-236 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $23,486 - $50,935	236 New	236 $36 Million
Q3 2020 Nov 13, 2020	SELL	$89.56 - $126.72 $83,559 - $118,229	-933 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $63,705 - $115,365	933 New	933 $104 Million

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.